Navigation Links
Lung Cancer Trial Targets Asbestos-Related Disease
Date:7/21/2008

Chemo-radiation therapy looks to kill cells on organ's surface, spare surrounding tissue

MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that's almost always caused by exposure to asbestos.

Currently, the standard treatment is to remove the affected lung.

"Current surgical and chemotherapy treatments of patients with malignant pleural mesothelioma are unsatisfactory and have not been shown to significantly prolong survival. In this study, we will investigate whether a combination of chemotherapy and radiation targeted directly at the lung's lining can improve outcomes while avoiding surgery," principal investigator Dr. Robert Taub, director of the Mesothelioma Center at New York-Presbyterian Hospital and Columbia University Medical Center, said in a news release.

"The trial is also significant, because our center is the only one nationwide that is offering this experimental therapy to treat pleural mesothelioma," Taub said.

It's expected the targeted radiation will kill cancer cells on the surface of the lung while sparing other parts of the lung and surrounding vital tissues.

Patients aged 18 and older who have not had recent radiation therapy or chemotherapy and have not received prior Alimta chemotherapy will be considered for the study.

Patients enrolled in the study will receive several rounds of targeted chemotherapy using the drugs cisplatin and doxorubicin via surgically implanted catheters. Some patients will be randomly selected to receive additional systemic (intravenous) chemotherapy using the drugs cisplatin and pemetrexed. All patients will receive targeted radiotherapy using the P-32 radioisotope. Patients may elect to receive additional surgical treatment, including removal of the affected lung lining or lung.

For more about the study, call 212-305-6837.

More information

The American Cancer Society has more about malignant mesothelioma.



SOURCE: New York-Presbyterian Hospital and Columbia University Medical Center, news release, June 26, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
2. Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology
3. New approach to cancer: Find most tightly controlled genes
4. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
5. Weizmann Institute scientists new technique gets to the root of cancer
6. Using magenetic nanoparticles to combat cancer
7. Researchers Find Link Between Organ Transplants, Cancer
8. Physicians Practice and Nevada Cancer Institute Partner to Improve Patient Care
9. Focused Internet services provide better support to breast cancer patients
10. Possible link found between X-rays and prostate cancer
11. Brain Cancer Vaccines Immune Response Key to Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution of ... current obstacles facing infection prevention and offer strategies for the health care community ... , The print component of “Fighting Infection” is distributed within the Friday, ...
(Date:3/24/2017)... ... , ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the ... clinic is the group’s 7th location in San Antonio and 23rd in Texas. ... care from the clinic, which opened March 22, 2017. , The team ...
(Date:3/24/2017)... ... March 24, 2017 , ... As the standards ... a communications platform that positions them as the go-to thought leader in all ... online publication as an always-on, always-fresh news, views and advocacy engine, called ONS ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... ... and Harvest A Cultivation of Christian Love” is the creation of published author, David ... wife, Anna Marie. He and his wife are the proud parents of four grown ... “Shadow and Substance.” , “Love, the agape kind, is seen as more than an ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the "Deep ... to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 report examines ... deep learning solutions within the healthcare domain. Primarily driven by the ... solution to generate relevant insights from medical data. ...
(Date:3/24/2017)... , March 24, 2017 Global ... industry including definitions, classifications, applications and industry chain structure. ... market including development history, competitive landscape analysis, and major ... ... spread across 105 pages providing 10 company profiles and ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
Breaking Medicine Technology: